Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications.
OBJECTIVE
To determine the relation between ASA ingestion and the incidence of bleeding complications after transrectal ultrasound (TRUS)-guided biopsy of the prostate.


METHODS
Overall, 1810 patients with suspected prostate disease were followed after biopsy. ASA use was determined before the procedure. A TRUS-guided sextant biopsy was performed and patients were contacted immediately and by follow-up telephone call to determine whether there were any immediate or delayed bleeding complications.


RESULTS
Overall, 46 subjects (2.5%) had bleeding complications. Of the 54 subjects reporting current use of ASA, 2 (3.7%) had such complications. This difference was not significant.


CONCLUSIONS
There was no evidence of an association between the use of ASA and postbiopsy bleeding complications.
Herget
E J
EJ
Department of Diagnostic Imaging, Foothills Hospital, Calgary, Alta.
Saliken
J C
JC
Donnelly
B J
BJ
Gray
R R
RR
Wiseman
D
D
Brunet
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D001707:Biopsy, Needle / Q000295:instrumentation*; D019160:Endosonography / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D011446:Prospective Studies; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology*; D012007:Rectum; D012307:Risk Factors
D001241:Aspirin